您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

李劭軒醫師

乳癌、肺癌、大腸直腸癌、食道癌、頭頸部腫瘤
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚醫院 血液腫瘤科主治醫師
  • 學歷
    • 高雄醫學大學醫學系畢業
  • 經歷
    • 高雄長庚醫院 內科部住院醫師
    • 高雄長庚醫院 血液腫瘤科住院醫師
  • 學會與認證
    • 台灣內科醫學會
    • 中華民國癌症醫學會
  • 論文及期刊發表
    • High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep. 2017 Nov;16(5):7185-7190. (SCI; IF=1.692; Medicine, research & experimental=85/128)

      Rau KM*, Su YL, Li SH, Hsieh MC, Wu SC, Chou FF, Chiu TJ, Chen YH, Liu CT.
    • Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer. J Cancer. 2017 Jul 20;8(12):2247-2255. (SCI; IF=2.916,Oncology 113/217)

      Lu CH, Liu CT, Chang PH, Hung CY, Li SH, Yeh TS, Hung YS, Chou WC*.
    • Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. International Journal of Head and Neck Science 1(2): 121-130, 2017. (non SCI; corresponding author*)

      Tai-Jan Chiu, Sheng-Dean Luo, Chih-Yen Chien, Yan-Ye Su, Tai-Lin Huang, Wei-Che Lin,Fu-Min Fang, Chang-Han Chen, Shun-Yu Su, Li SH* .
    • Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer. Onco Targets Ther. 2017; 10: 3917–3924. (SCI; IF=2.612; Biotechnology & applied microbiology 61/160)

      Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY*.
    • Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma. J Renin Angiotensin Aldosterone Syst. 2017 Jul-Sep;18(3):1470320317717904. (SCI; IF=1.396; Peripheral vascular disease 51/63; corresponding author*)

      Su YY, Chen CH, Chien CY, Lin WC, Huang WT, Li SH*.
    • A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy. J Thorac Dis. 2017 Jun; 9(6): 1446–1449. (SCI; IF=2.365; Respiratory system 36/59; corresponding author*)

      Chang-Han Chen, Li SH*.
    • The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer. PLoS One. 2017 Jun 7;12(6):e0178676 (SCI; IF=2.806; Multidisciplinary sciences 15/64).

      Chang YP, Chen YM, Lai CH, Lin CY, Fang WF, Huang CH, Li SH, Chen HC, Wang CC, Lin MC.
    • Screening for Psychologic Distress in Taiwanese Cancer Inpatients Using the National Comprehensive Cancer Network Distress Thermometer: The Effects of Patients’ Sex and Chemotherapy Experience. Psychosomatics. 2017 Apr 6. pii: S0033-3182(17)30093-2. (SCI; IF=1.436; PSYCHOLOGY 52/77)

      Chiou YJ, Lee CY, Li SH, Chong MY, Lee Y, Wang LJ.
    • Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson` Disease. Oxid Med Cell Longev. 2017;2017:7371403. doi: 10.1155/2017/7371403. Epub 2017 Jan 23. (SCI; IF=4.593, Cell biology 56/180)

      Chen MH, Chen PC, Lu CH, Chen HL, Chao YP, Li SH, Chen YW, Lin WC.
    • Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma. PLoS One. 2017 Feb 28;12(2):e0172752 (SCI; IF=2.806; Multidisciplinary sciences 15/64; corresponding author*)

      Chen CH, Lu HI, Wang YM, Chen YH, Lo CM, Huang WT, Li SH*.
    • Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncol. 2017 Mar;18(3):323-335. (SCI; IF=33.9; Oncology 3/217)

      Soulieres D, Faivre S, Mesia R, Remenar E, Li SH, Karpenko A, Dechaphunkul A, Ochsenreither S, Kiss LA, Lin JC, Nagarkar R, Tamas L, Kim SB, Erfan J, Alyasova A, Kasper S, Barone C, Turri S, Chakravartty A, Chol M, Aimone P, Hirawat S, Licitra L.
    • Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. Scientific Reports. 2017 Jan 30;7:41785 (SCI; IF=4.259; Multidisciplinary sciences 10/64; corresponding author*)

      Chen YH, Lu HI, Chien CY, Lo CM, Wang YM, Chou SY, Su YY, Shih LH, Li SH*.
    • FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy. BMC Med Imaging. 2017 Jan 5;17(1):1 (SCI; IF=1.060; Radiology, Nuclear medicine & Medical imaging 104/127; corresponding author*)

      Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH*.
    • Prevalence and related factors of psychological distress among cancer inpatients